Home > Rheumatology > ‘Reassuring’ data on cardiac toxicity with hydroxychloroquine in RA, lupus

‘Reassuring’ data on cardiac toxicity with hydroxychloroquine in RA, lupus

ACR 2020
Reuters Health - 09/11/2020 - Hydroxychloroquine has no significant impact on heart rhythm in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), according to two studies featured at a press briefing at ACR Convergence, the 2020 annual virtual meeting of the American College of Rheumatology. "Our findings really do reinforce the fact that hydroxychloroquine is a safe and effective long-term disease-modifying drug for our rheumatic patients," said Dr. Elizabeth Park, of Columbia University in New York City, co-author of one of the studies. "With these data, we can reassure both prescribing providers and our patients that this drug is effective and safe," said Dr. H. Michael Belmont, co-director of the NYU Lupus Center in New York City, who worked on the other study. Hydroxychloroquine (HCQ) is a "cornerstone" of treatment for SLE and patients with RA may also take this drug alone or in combination with other treatments, Dr. Park note...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on